Atlas Trials

A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS

Clinical trial NCT01573533 · COMPLETED

Trial details

NCT number
NCT01573533
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Focal Segmental Glomerulosclerosis
Start date
2013-10-01
Primary completion
2018-11-15
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.